IACH News Podcasts

Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access.

September 10th- Dr. Bruno Paiva- Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment

CME Congresses .

September 10th- Dr. Bruno Paiva- Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment

September 4th- Dr. Raffaela Greco- High incidence of severe TA-TMA increases mortality in adult allogeneic transplant recipients: A prospective MIDAS consortium study

CME Congresses .

September 4th- Dr. Raffaela Greco- High incidence of severe TA-TMA increases mortality in adult allogeneic transplant recipients: A prospective MIDAS consortium study

July 29th- Dr. Juan Carlos Hernández-Boluda- Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis

CME Congresses .

July 29th- Dr. Juan Carlos Hernández-Boluda- Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis

July 11th- Prof. Thomas Cluzeau- Overall Survival and Duration of Transfusion Independence for First-Line ESA-Naive Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept vs Epoetin Alfa in the COMMANDS Trial

CME Congresses .

July 11th- Prof. Thomas Cluzeau- Overall Survival and Duration of Transfusion Independence for First-Line ESA-Naive Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept vs Epoetin Alfa in the COMMANDS Trial

July 8th- Dr. Ofir Wolach- Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study

CME Congresses .

July 8th- Dr. Ofir Wolach- Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study

July 3rd- Prof. Ola Landrgen- Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS

CME Congresses .

July 3rd- Prof. Ola Landrgen- Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Mohamad Mohty- Best of myélome à l'EHA 2025

CME Congresses .

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Mohamad Mohty- Best of myélome à l’EHA 2025

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Arthur Bobin- ISASOCUT

CME Congresses .

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Arthur Bobin- ISASOCUT

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Jean-Marc Schiano- Le myélome de haut risque

CME Congresses .

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Jean-Marc Schiano- Le myélome de haut risque

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Dr. Levy- Les recommandation EHA-EMN

CME Congresses .

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Dr. Levy- Les recommandation EHA-EMN